Go To Global Site
Welcome to UCB in the United States
Alisha_Bridges_1280x960

Aug

29

The Day Psoriasis Stopped Stopping Me

As part of Psoriasis Action Month, Alisha Bridges, an award-winning writer and community advocate, recently shared her story about living with psoriasis.

9q0ipi0055

Aug

23

UCB Runners Lace Up to Support Patients

UCB supports local events across the country that benefit patients. Recently, our employees participated in two different runs in support of the epilepsy and Crohn’s disease communities.

Aug

13

Press Release: FDA Accepts New Drug Application (NDA) to review Midazolam Nasal Spray, an investigational product for the acute treatment of seizure clusters

FDA Accepts New Drug Application (NDA) to review Midazolam Nasal Spray, an investigational product for the acute treatment of seizure clusters

MHT_Spondylitis_Webpage_1280v960_for_Blog

Aug

08

New Resource for Those Living with Spondyloarthritis

An estimated 3.3 million individuals in the U.S. are living with spondyloarthritis1,2 (SpA), an inflammatory disease affecting the spine, and in some people, the joints of the arms and legs, skin, intestines, and eyes. An underdiagnosed condition, most people with SpA first experience symptoms in their 20s or 30s but typically wait as many as 10 years between symptom onset and SpA diagnosis. * 

PsO_Patient_1280x960

Aug

01

Disease Spotlight: Psoriasis

August is Psoriasis Awareness Month so we’re shining a spotlight on the disease and how UCB is working to deliver solutions that patients value.